Business
AstraZeneca puts COVID-19 vaccine trial on hold – The Australian Financial Review
The drug maker said its “standard review process triggered a pause to vaccination to allow review of safety data”.
AstraZeneca has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news website Stat News reported.
It quoted an AstraZeneca spokesperson as saying in a statement that the “standard review process triggered a pause to vaccination to allow review of safety data.
Nine leading US and European vaccine developers pledged on Tuesday to uphold scientific safety and efficacy standards for the…
Continue Reading
